EUVIMEDEUVIMED entdecken
Crossref

L26/P-777 Embryological competence following progestin-primed ovarian stimulation compared with GnRH antagonist cycles: evidence from a prospective cohort

F. Seethi, K. Kinattingal, R. Jabir, S. Devi C

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.1104 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von F. Seethi und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does progestin-primed ovarian stimulation influence fertilization and embryo developmental competence compared with GnRH antagonist cycles in a prospective cohort? Summary answer Fertilization efficiency, blastulation, and embryo developmental competence were preserved with progestin-primed ovarian stimulation across completed and recent prospective cohorts. What is known already Progestin-primed ovarian stimulation (PPOS) effectively suppresses premature LH surge and is increasingly adopted in IVF practice. However, concerns persist regarding potential effects of progestins on oocyte quality, fertilization, and subsequent embryo development. Published data are conflicting, and most available studies are retrospective. Prospective comparative embryology data evaluating fertilization and blastulation outcomes in routine clinical practice remain limited. Study design, size, duration Prospective, non-randomized comparative cohort study conducted over 2.5 years, including a completed cohort and an extended ongoing cohort. Participants/materials, setting, methods The completed cohort included 63 PPOS cycles and 51 GnRH antagonist cycles. The extended cohort comprised 48 additional PPOS cycles with 1:1 matched historical antagonist controls selected based on age, AMH and AFC. Embryology endpoints included mature oocytes (MII), normally fertilized embryos (2PN), fertilization rate (2PN/MII), and blastulation rate per 2PN embryo. Main results and the role of chance In the completed cohort, PPOS cycles yielded fewer mature oocytes (MII 3.9 ± 2.1 vs 6.0 ± 2.2; p < 0.001) and fewer normally fertilized embryos (2PN 2.1 ± 1.4 vs 3.8 ± 2.1; p < 0.001), while fertilization rates were comparable (2PN/MII 0.57 ± 0.23 vs 0.62 ± 0.22; p = 0.25). Blastulation rate per 2PN embryo was similar between PPOS and antagonist cycles, indicating preserved developmental progression. In the extended cohort, PPOS cycles demonstrated higher MII yield (8.1 ± 4.3 vs 6.0 ± 2.2; p = 0.005), higher number of 2PN embryos (5.9 ± 3.6 vs 3.8 ± 2.1; p < 0.001), higher fertilization rate (0.73 ± 0.22 vs 0.61 ± 0.22; p = 0.011), and maintained blastulation rates compared with matched controls. Across both cohorts, no adverse effect of PPOS on embryo developmental competence was observed. Limitations, reasons for caution The non-randomized design may introduce selection bias, and embryology outcomes may be influenced by ovarian response and stimulation characteristics. Wider implications of the findings These prospective data support the embryological safety of PPOS, demonstrating preserved fertilization and blastulation, and reinforcing its suitability for routine IVF practice. Trial registration number No

Zitieren

APA

Seethi, F., Kinattingal, K., Jabir, R., & C, S. D. (2026). L26/P-777 Embryological competence following progestin-primed ovarian stimulation compared with GnRH antagonist cycles: evidence from a prospective cohort. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1104

Vancouver

Seethi F, Kinattingal K, Jabir R, C SD. L26/P-777 Embryological competence following progestin-primed ovarian stimulation compared with GnRH antagonist cycles: evidence from a prospective cohort. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1104

BibTeX
@article{Seethi2026,
  author = {Seethi, F. and Kinattingal, K. and Jabir, R. and C, S. Devi},
  title = {L26/P-777 Embryological competence following progestin-primed ovarian stimulation compared with GnRH antagonist cycles: evidence from a prospective cohort},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.1104}
}
Kostenlos starten →